PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC
Clinical trial NCT06062602 · COMPLETED
Trial details
- NCT number
- NCT06062602
- Sponsor
- Presage Biosciences
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2022-11-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.